New Warning Adds Memory Loss to List of Zocor Side Effects
The FDA recently issued a new warning for statins, after reviewing information regarding Zocor side effects like memory loss and type II diabetes. The agency added a warning to Zocor packaging that states use of statins like Zocor could increase the risk of cognitive symptoms, including confusion and memory loss. The side effects were primarily seen in patients over the age of 50, although they could occur in Zocor users of any age.
While it remains to be seen how this new information could impact Zocor lawsuits in the future, reports have made some Zocor users wonder whether the benefits of the drug outweigh the risks.
Zocor side effects rare, but warning still issued
According to a report at Forbes, the FDA chose to add the warning of new statin side effects, like Zocor diabetes, despite evidence showing that the risk is still relatively small.
Forbes estimated that around 20 million Americans are currently taking a cholesterol-lowering statin drug like Zocor. Some have filed Zocor lawsuits after experiencing serious side effects like Zocor muscle injury and liver damage. Now, a Zocor lawyer might evaluate the eligibility of clients who report cognitive conditions like memory loss and confusion.
The association between cognitive function and statin use is not necessarily new. Questions about side effects like Zocor memory loss surfaced a number of years ago, when a doctor at New York Presbyterian Hospital, Dr. Orli Entingin, told the Wall Street Journal that some of her patients taking atorvastatin were experiencing serious memory loss.
Despite a lack of solid data, anecdotal evidence has been a significant concern for some physicians. Dr. Gayatri Devi from the New York University School of Medicine told Heart.org in 2008 that six of her patients were treated for memory loss within six weeks after beginning statin therapy.
“It’s a handful of patients, but for them, it made a huge difference,” Dr. Devi explained.
Zocor lawsuits may begin to encompass new symptoms
The FDA is expected to add Zocor diabetes and other new side effects to drug packaging this month, and a Zocor lawyer may wonder how this new information will impact Zocor lawsuits in the future.
Patients who experienced cognitive impairment prior to the warning may be able to argue that they were unaware of the risks when they began statin therapy. Current research has only examined short-term effects on cognitive ability; additional research needs to be done on the long-term effects of statins as well.
As the new FDA warning is scheduled to be added, Zocor lawsuits with new and expanded allegations may be landing in courts in the future.